Precision Optics (NasdaqCM:POCI) Q2 2026 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsJoe Forkey - CEORobert Blum - Managing Partner and Managing Investor RelationsWayne Coll - CFOOperatorGood day, and welcome to the Precision Optics Reports second quarter fiscal year 2026 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, ...

Core Viewpoint - Macquarie's report indicates that Pop Mart's Valentine's Day limited edition blind box series has been well-received, with the first batch selling out quickly. The firm believes that Pop Mart's diverse product and IP portfolio will continue to drive consumer engagement and revenue growth, projecting that the contribution of its top two to six IPs to revenue will increase from 43% in 2025 to 48.6% this year [1]. Group 1 - The first batch of Pop Mart's Valentine's Day limited edition blind box series sold out rapidly, indicating strong consumer demand [1]. - Macquarie expects the revenue contribution from Pop Mart's top IPs to rise from 43% in 2025 to 48.6% in the current year, reflecting the company's effective product development and consumer interaction strategies [1]. - Recent stock price adjustments are attributed to investor concerns over the slowdown in Pop Mart's U.S. market operations, which Macquarie believes is an overreaction [1]. Group 2 - Macquarie maintains a "Outperform" rating for Pop Mart, with a target price of 470 HKD, citing optimism about production capacity expansion supporting sales growth [2]. - Citigroup has reiterated a "Buy" rating for Pop Mart, highlighting confidence in new product launches and share buybacks [2].

Financial Data and Key Metrics Changes - The company has maintained a strong dividend yield of 11% [1] - The impact of tariffs has led to a pullback in production, affecting inventory levels and sales [18][22] Business Line Data and Key Metrics Changes - The company has expanded its product lines through strategic acquisitions, including entering the toy market and developing higher-end toys [3] - The company holds significant market share in various categories, with 80%-90% in bibs and toddler bedding [19] Market Data and Key Metrics Changes - The birth rate has stabilized, with a slight increase in 2024, which is a positive indicator for the company [12] - The company has observed a trade-down effect among consumers, with lower-priced products gaining traction [15] Company Strategy and Development Direction - The company aims to focus on organic product development and international expansion while maintaining its core business in infant and toddler products [39][41] - The company is exploring opportunities for growth in existing product lines and adjacent categories, while being cautious about entering lower-margin markets [39] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for fiscal 2027, anticipating improvements as tariffs stabilize and inventory levels are managed [18][22] - The competitive landscape is mixed, with the company being a leader in some categories while having room for growth in others [19][20] Other Important Information - The company is currently focused on reducing debt levels while maintaining profitability through cost-saving measures [34][31] - Inventory management is a priority, with plans to consolidate warehouses in the coming years [30] Q&A Session Summary Question: How does the company target expectant mothers and growing families? - The company utilizes social media platforms like Facebook and Instagram to reach expectant mothers and leverage word-of-mouth marketing among parents [50] Question: How important are licenses to the product mix? - Licenses are crucial, especially in toddler bedding, where they account for about 95% of the category [54] Question: How does the company view its dividend policy? - Maintaining the regular dividend is important, but special dividends are unlikely while focusing on debt reduction [55]

Core Insights - The company reported good profitability and continued investments in its business despite a turbulent market environment [1] - Order intake experienced a decline primarily due to delays in larger investments, although business showed signs of recovery in September [1] - The second quarter's strong performance positively influenced currency-neutral sales growth, making Q3 the most profitable quarter of the year despite negative currency and tariff impacts [2] Financial Performance - The company focused on operational efficiency and product development, launching several new products during the quarter [2] - The company has strengthened its leading position in the industrial air filtration sector [2]

Core Viewpoint - Amway Co., Ltd. (300218) is actively advancing product development and validation for new automotive interior and electronic product projects based on customer demands, indicating a strategic focus on innovation and customer-centric solutions [1] Group 1 - Since 2025, Amway's production and sales in Vietnam have steadily increased, reflecting improved operational performance [1] - The company's production scale and order acceptance capability have strengthened compared to previous periods, contributing to enhanced capacity utilization [1] - The overall business condition is improving, which is expected to positively impact the company's economic benefits [1]

Core Viewpoint - The company is currently focused on market expansion and product development, particularly in the context of its newly established subsidiary, Jingzhi Technology [1] Group 1 - The company established Jingzhi Technology in June 2025 [1] - The main focus is on advancing production capacity and engaging in deep technical exchanges with domestic and international clients [1] - The company aims to further optimize algorithms and material processes [1]

Core Viewpoint - The company is focusing on developing core component products based on its own technological accumulation, starting with a foundational platform and standard products, then customizing according to customer needs [1] Group 1 - The company is currently building a basic platform and developing standardized products [1] - The company guides customers with unclear demands to use existing platform solutions [1] - The company is exploring more efficient management models to enhance R&D efficiency and decision-making speed [1]

Summary of Key Points from the Conference Call Industry Overview - The small home appliance industry entered a plateau phase after 2021, but new categories like air fryers and coffee machines showed remarkable growth in 2022, with air fryers increasing by 88% and coffee machines by 41% [1][2][4]. - The macroeconomic downturn in 2023-2024 is expected to impact consumer spending, but the national subsidy policy in Q4 2024 is anticipated to boost confidence, particularly benefiting mid-to-high-end products [1][2][4]. Core Insights and Arguments - By 2025, small appliance companies are expected to face a mild recovery in demand, reduced competition, and improved profitability, driven by fiscal subsidies and low base effects [1][4]. - Online sales channels have become the mainstream for small appliances, accounting for 79% of sales, with platforms implementing cost-reduction policies to alleviate pressure on brands [1][5]. - Brands like Xiaoxiong are optimizing product structures and focusing on high-end products to enhance brand image and profitability, while also emphasizing marketing efficiency and supply chain cost reduction [1][6]. Future Trends and Recommendations - The kitchen small appliance market is projected to recover in 2025, with significant price-driven growth expected. The domestic market is entering a phase of enhanced product capabilities [1][7]. - Recommended companies to watch include Xiaoxiong, Feike, Delma, and the stable dividend-paying leader Supor, as well as the promising water purification company Yunmi Technology [1][7]. Market Environment and Strategic Directions - Current market conditions for small appliance companies include moderate demand recovery, easing competition, and improving profitability, with a focus on high-quality development [4]. - Companies are adopting various strategic directions, including market penetration, product development, market expansion, and diversification to adapt to the plateau phase [8][10]. - The mother and baby small appliance market is particularly strong, with Xiaoxiong's revenue in this segment growing by 32% in 2024, outperforming other business areas [2][9]. Additional Important Insights - The online retail share of kitchen small appliances rose from 55% in 2019 to 67% in 2020 due to the pandemic, with brands like Xiaoxiong, Beiding, and Xinbao seeing significant revenue growth [2]. - Platforms are shifting their strategies towards GMV (Gross Merchandise Volume) to enhance user engagement, repeat purchase rates, and average transaction value, leading to a reduction in price competition [5]. - Companies are increasingly focusing on overseas markets due to prolonged domestic demand weakness, with brands like Xiaoxiong and Beiding achieving substantial growth in international sales [10].

Financial Data and Key Metrics Changes - Revenue grew 41.1% to $148.1 million from $105 million year-over-year [17] - Operating income increased 45% [5] - EPS grew 34.8% to $2.21 [18] - Adjusted EBITDA increased 45.9% to $30.2 million [19] - Gross margin slightly decreased to 28.5% from 28.6% [17] Business Line Data and Key Metrics Changes - Medical business revenue grew 50.4% to $135.4 million, becoming the second largest segment [17][5] - Interventional and Surgical, Infection Prevention, Orthopedics, and Advanced Wound Care segments all grew by more than 25% [6] - Advanced Components saw a decline of 16.3% as resources were focused on MedTech opportunities [7] - Robotic Surgery declined 6% in Q1, with modest growth anticipated for 2025 [7] Market Data and Key Metrics Changes - Sales to the medical market increased significantly while sales to all other markets decreased by 15% [17] - The SAFE patient handling business is strategically important, adding a high-growth market segment to the Medicare portfolio [6] Company Strategy and Development Direction - The company is executing a two-pronged growth strategy focused on expanding in high-growth markets and pursuing strategic acquisitions [12] - New programs in robotic surgery are set to launch later this year, with ongoing discussions with the largest robotic surgery partner [8] - Expansion plans in the Dominican Republic are underway, including a new facility to support growth in the SAFE patient handling business [9][11] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about future growth despite anticipated inefficiencies in newly acquired operations [11] - The company does not expect a material impact from tariffs, with confidence in passing on most tariff costs [14][15] - Management is focused on continuous improvement and efficiency across all business aspects [13] Other Important Information - The company has completed a small acquisition to enhance manufacturing capacity for the SAFE patient handling business [12] - The effective tax rate for Q1 was 15.3%, with a normalized rate suggested at 21% to 23% for 2025 [18] Q&A Session Summary Question: Clarification on robotic surgery business growth - Management indicated modest growth expectations for both the largest customer and the robotic surgery business as a whole, with a decline in Q1 attributed to large equipment sales in the previous year [22][23] Question: Commentary on market share with the largest customer - Current understanding is that the company holds about two-thirds of the market share with the largest customer, with a positive relationship and transparency in operations [24][26] Question: Excess inventory at customers - Management reported no significant excess inventory at customers, indicating a return to normal business operations [28] Question: Growth in segments outside robotics - Positive growth in infection prevention and interventional segments was noted, with destocking headwinds behind the company [34][36] Question: Impact of price reductions on revenue growth - Price reductions during transfers are expected to be around 15% to 20%, but market growth may offset revenue impacts over time [60][62] Question: Inefficiencies at AJR and their impact on P&L - Inefficiencies are expected to continue through Q2, affecting direct labor costs, but improvements are anticipated as staffing stabilizes [65] Question: Long-term footprint and expansion plans - The company remains committed to expansion in the Dominican Republic and is exploring opportunities in Asia Pacific to better serve customer needs [68][69]